C Partners Holding’s Alexion Pharmaceuticals ALXN Stock Holding History

C Partners Holding’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,250	Closed	-$949K	–	39
2015 Q2	$949K	Buy	+5,250	New	+$906K	0.44%	35

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

C Partners Holding's ALXN Position: Q3 2015 in Review

C Partners Holding sold out of Alexion Pharmaceuticals (ALXN) in Q3 2015, closing a stake of 5,250 shares — an estimated $949K sold.

C Partners Holding first reported a position in ALXN in Q2 2015 and held it in 1 quarter. The position peaked at $949K in Q2 2015. 513 funds tracked by Wall St. Rank hold ALXN as of Q3 2015.

C Partners Holding reported no remaining Alexion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
C Partners Holding sold 5,250 Alexion Pharmaceuticals shares in Q3 2015, an estimated $949K.
C Partners Holding first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 1 quarter.
C Partners Holding's Alexion Pharmaceuticals position peaked at $949K in Q2 2015.
513 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2015.

Based on C Partners Holding's 13F filing for Q3 2015, filed 12 Nov 2015.